Home › Companies › NEURONETICS INC. › 2024-2025
At NEURONETICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held November 8, 2024 and May 22, 2025), 57 asset managers reported how they voted in their SEC Form N-PX filings, covering 335 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held May 22, 2025 — Approval, on a non-binding, advisory basis, of the compensation of our named executive officers. — NEURONETICS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NEURONETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 28, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and NEURONETICS INC.’s Form 8-K, filed May 28, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 22, 2025: 10 items on NEURONETICS INC.’s Form 8-K, filed May 28, 2025: 7 elected · 2 approved · 1 not approved.
Meeting of November 8, 2024: 4 items on NEURONETICS INC.’s Form 8-K, filed November 12, 2024: 4 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore NEURONETICS INC. in the interactive database Compare manager voting policies
These tallies are NEURONETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. NEURONETICS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Avinash N. Amin, M.D. | 37,672,404 | -- | -- | 45,557 | 15,845,714 | 99.8% | Elected | — |
| Elect Director: Robert A. Cascella | 36,984,585 | -- | -- | 733,376 | 15,845,714 | 98% | Elected | — |
| Elect Director: Sheryl L. Conley | 36,907,654 | -- | -- | 810,307 | 15,845,714 | 98% | Elected | — |
| Elect Director: Sasha S. Cucuz | 37,671,953 | -- | -- | 46,008 | 15,845,714 | 99.8% | Elected | — |
| Elect Director: Glenn P. Muir | 36,984,528 | -- | -- | 733,433 | 15,845,714 | 98% | Elected | — |
| Elect Director: Megan R. Rosengarten | 36,762,273 | -- | -- | 955,688 | 15,845,714 | 97% | Elected | — |
| Elect Director: Keith J. Sullivan | 36,987,446 | -- | -- | 730,515 | 15,845,714 | 98% | Elected | — |
| 2. Appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 53,498,731 | 12,970 | 51,974 | -- | -- | 99.9% | Approved | — |
| 3. Approval, on a non-binding, advisory basis, of the compensation of the individual who served as our principal executive officer during 2024 and our two other most highly compensated executive officers who were serving as executive officers as of December 31 | 36,970,048 | 708,469 | 39,444 | -- | 15,845,714 | 98% | Approved | — |
| 4. Approval of amendments to our certificate of incorporation and bylaws to eliminate supermajority voting requirements | 11,685,491 | 25,644,606 | 202,413 | -- | 16,031,165 | 31% | Not approved | — |
Source: NEURONETICS INC., Form 8-K, filed with the SEC on May 28, 2025 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Neuronetics Charter Amendment Proposal | 16,658,874 | 7,332,833 | 17,163 | -- | -- | 69% | Approved | — |
| 2. Neuronetics Share Issuance Proposal | 11,956,848 | 5,728,604 | 12,409 | -- | 6,311,009 | 68% | Approved | a majority of the votes cast |
| 3. Neuronetics Incentive Plan Proposal | 9,479,422 | 8,207,011 | 11,428 | -- | 6,311,009 | 53.6% | Approved | a majority of the votes cast |
| 4. Neuronetics Adjournment Proposal | 16,117,186 | 7,559,390 | 332,294 | -- | -- | 68% | Approved | a majority of the shares outstanding |
Source: NEURONETICS INC., Form 8-K, filed with the SEC on November 12, 2024 — read the filing on EDGAR.
Each item below shows how the 57 asset managers that disclosed a NEURONETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NEURONETICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Avinash N. Amin, M.D.
NEURONETICS INC.’s own tally for this item (“Elect Director: Avinash N. Amin, M.D.”): 37,672,404 for, 45,557 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Glenn P. Muir
NEURONETICS INC.’s own tally for this item (“Elect Director: Glenn P. Muir”): 36,984,528 for, 733,433 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Keith J. Sullivan
NEURONETICS INC.’s own tally for this item (“Elect Director: Keith J. Sullivan”): 36,987,446 for, 730,515 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Megan R. Rosengarten
NEURONETICS INC.’s own tally for this item (“Elect Director: Megan R. Rosengarten”): 36,762,273 for, 955,688 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Robert A. Cascella
NEURONETICS INC.’s own tally for this item (“Elect Director: Robert A. Cascella”): 36,984,585 for, 733,376 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Sasha S. Cucuz
NEURONETICS INC.’s own tally for this item (“Elect Director: Sasha S. Cucuz”): 37,671,953 for, 46,008 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Sheryl L. Conley
NEURONETICS INC.’s own tally for this item (“Elect Director: Sheryl L. Conley”): 36,907,654 for, 810,307 withheld, per its Form 8-K filed May 28, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2026 Annual Meeting, or until their respective successors are elected and qualified, by th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,958,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
31% Not approved · of votes cast
Description as filed by funds: Amendments to our certificate of incorporation and bylaws to eliminate supermajority voting requirements.
NEURONETICS INC.’s own tally for this item (“4. Approval of amendments to our certificate of incorporation and bylaws to eliminate supermajority voting requirements”): 11,685,491 for, 25,644,606 against — failed, per its Form 8-K filed May 28, 2025 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “Proposal 4: The approval of amendments to our certificate of incorporation and bylaws to eliminate supermajority voting requirements was not approved by the Company's stockholders by the votes set forth in the table below:”
Support: 31% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 2,885,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| Equitable | 5,151 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Meeting held November 8, 2024.
100% of fund votes cast · no official result
Description as filed by funds: APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE NEURONETICS RESTATED CERTIFICATE OF INCORPORATION TO INCREASE NEURONETICS' AUTHORIZED SHARES OF COMMON STOCK FROM 200,000,000 SHARES TO 250,000,000 SHARES.
The 10 asset managers below reported 1,823,676 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,291,381 | 0 | 0 | 0 | For |
| Fidelity | 300,239 | 0 | 0 | 0 | For |
| Equitable | 69,626 | 0 | 0 | 0 | For |
| BlackRock | 62,476 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 45,205 | 0 | 0 | 0 | For |
| Gabelli | 42,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 12,000 | 0 | 0 | 0 | For |
| John Hancock | 550 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 100 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 99 | 0 | 0 | 0 | For |
Meeting held November 8, 2024.
68% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE ISSUANCE OF SUCH NUMBER OF SHARES OF NEURONETICS COMMON STOCK TO GREENBROOK SHAREHOLDERS IN CONNECTION WITH THE ARRANGEMENT AGREEMENT.
NEURONETICS INC.’s own tally for this item (“2. Neuronetics Share Issuance Proposal”): 11,956,848 for, 5,728,604 against — passed, per its Form 8-K filed November 12, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Neuronetics Share Issuance Proposal received the affirmative vote of approximately 67.56% of Neuronetics Shares represented at the Special Meeting and entitled to vote on this proposal and, therefore, was approved.”
Support: 68% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the votes cast (“majority of votes cast”).
The 10 asset managers below reported 1,823,676 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,291,381 | 0 | 0 | 0 | For |
| Fidelity | 300,239 | 0 | 0 | 0 | For |
| Equitable | 69,626 | 0 | 0 | 0 | For |
| BlackRock | 62,476 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 45,205 | 0 | 0 | 0 | For |
| Gabelli | 42,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 12,000 | 0 | 0 | 0 | For |
| John Hancock | 550 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 100 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 99 | 0 | 0 | 0 | For |
Meeting held November 8, 2024.
Combines 2 wordings of this item as funds reported it.
98% of fund votes cast · no official result
Description as filed by funds: SUBJECT TO THE PROVISIONS OF THE ARRANGEMENT AGREEMENT, APPROVAL OF THE ADJOURNMENT OF THE NEURONETICS SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES TO APPROVE THE AMENDMENT PROPOSAL AND THE SHARE ISSUANCE PROPOSAL.
The 10 asset managers below reported 1,794,077 for, 29,599 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,291,381 | 0 | 0 | 0 | For |
| Fidelity | 270,640 | 29,599 | 0 | 0 | Mixed |
| Equitable | 69,626 | 0 | 0 | 0 | For |
| BlackRock | 62,476 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 45,205 | 0 | 0 | 0 | For |
| Gabelli | 42,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 12,000 | 0 | 0 | 0 | For |
| John Hancock | 550 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 100 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 99 | 0 | 0 | 0 | For |
Meeting held November 8, 2024.
6% of fund votes cast · no official result
Description as filed by funds: APPROVAL OF AN AMENDMENT TO THE NEURONETICS INCENTIVE PLAN TO INCREASE THE NUMBER OF NEURONETICS SHARES RESERVED FOR ISSUANCE BY UP TO 3,500,000 ADDITIONAL SHARES.
The 10 asset managers below reported 118,000 for, 1,705,676 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 1,291,381 | 0 | 0 | Against |
| Fidelity | 0 | 300,239 | 0 | 0 | Against |
| Equitable | 64,000 | 5,626 | 0 | 0 | Mixed |
| BlackRock | 0 | 62,476 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 45,205 | 0 | 0 | Against |
| Gabelli | 42,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 12,000 | 0 | 0 | 0 | For |
| John Hancock | 0 | 550 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 100 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 99 | 0 | 0 | Against |
Meeting held November 8, 2024.
53.6% Approved · of votes cast
Description as filed by funds: Amendment to the Neuronetics Incentive Plan
NEURONETICS INC.’s own tally for this item (“3. Neuronetics Incentive Plan Proposal”): 9,479,422 for, 8,207,011 against — passed, per its Form 8-K filed November 12, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Neuronetics Incentive Plan Proposal received the affirmative vote of approximately 53.56% of Neuronetics Shares represented at the Special Meeting and entitled to vote on this proposal and, therefore, was approved.”
Support: 53.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the votes cast (“majority of votes cast”).
The 2 asset managers below reported 4,660 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ALGERT GLOBAL LLC | 4,260 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 400 | 0 | 0 | 0 | For |
Meeting held May 22, 2025.
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of our named executive officers.
NEURONETICS INC.’s own tally for this item (“3. Approval, on a non-binding, advisory basis, of the compensation of the individual who served as our principal executive officer during 2024 and our two other most highly compensated executive officers who were serving”): 36,970,048 for, 708,469 against — passed, per its Form 8-K filed May 28, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: The approval, on a non-binding, advisory basis, of the compensation of the individual who served as our principal executive officer during 2024 and our two other most highly compensated executive officers who were serving as executive officers as of December 31, 2024 was ratified by the…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of NEURONETICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on pay” (2 managers, 1,000 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Gabelli | 38,000 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 5,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Fund voting reports, all 11 managers: 3,001,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MASTERS CAPITAL MANAGEMENT LLC | 1,000,000 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 468,966 | 0 | 0 | 0 | For |
| Two Sigma | 415,127 | 0 | 0 | 0 | For |
| BlackRock | 338,785 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 321,507 | 0 | 0 | 0 | For |
| Point72 | 160,083 | 0 | 0 | 0 | For |
| Citadel | 104,778 | 0 | 0 | 0 | For |
| State Street | 88,422 | 0 | 0 | 0 | For |
| Informed Momentum Co LLC | 85,544 | 0 | 0 | 0 | For |
| Gabelli | 77,200 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 66,716 | 0 | 0 | 0 | For |
| Renaissance | 62,172 | 0 | 0 | 0 | For |
| OMERS ADMINISTRATION Corp | 57,500 | 0 | 0 | 0 | For |
| Northern Trust | 57,338 | 0 | 0 | 0 | For |
| GatePass Capital, LLC | 47,172 | 0 | 0 | 0 | For |
| Centiva Capital, LP | 37,869 | 0 | 0 | 0 | For |
| Fidelity | 31,602 | 0 | 0 | 0 | For |
| Capital Group | 22,797 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,100 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 17,339 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 15,000 | 0 | 0 | 0 | For |
| Vanguard | 10,950 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 10,052 | 0 | 0 | 0 | For |
| Prudential/PGIM | 6,400 | 0 | 0 | 0 | For |
Institutional-manager reports, all 45 managers: 3,548,249 for, 481 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held May 22, 2025.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the selection of KPMG LLP as our independent registered public accounting firm.
NEURONETICS INC.’s own tally for this item (“2. Appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 53,498,731 for, 12,970 against — passed, per its Form 8-K filed May 28, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified by the Company's stockholders by the votes set forth in the table below:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 3,001,133 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,297,536 | 0 | 0 | 0 | For |
| Fidelity | 298,829 | 0 | 0 | 0 | For |
| AdvisorShares Trust | 132,534 | 0 | 0 | 0 | For |
| Equitable | 78,151 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 72,166 | 0 | 0 | 0 | For |
| BlackRock | 61,620 | 0 | 0 | 0 | For |
| Gabelli | 38,000 | 0 | 0 | 0 | For |
| Charles Schwab | 15,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 5,000 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,800 | 0 | 0 | 0 | For |
| John Hancock | 497 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 65,820,344 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.49% |
| 2 | Fidelity | 0.45% |
| 3 | AdvisorShares Trust | 0.20% |
| 4 | Equitable | 0.12% |
| 5 | TIFF INVESTMENT PROGRAM | 0.11% |
| 6 | BlackRock | 0.09% |
| 7 | Gabelli | 0.06% |
| 8 | Charles Schwab | 0.02% |
| 9 | TETON WESTWOOD FUNDS | <0.01% |
| 10 | Blackstone Alternative Investment Funds | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | MASTERS CAPITAL MANAGEMENT LLC | 1.52% |
| 2 | BALYASNY ASSET MANAGEMENT L.P. | 0.71% |
| 3 | Two Sigma | 0.63% |
| 4 | BlackRock | 0.51% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.49% |
| 6 | Point72 | 0.24% |
| 7 | Citadel | 0.16% |
| 8 | State Street | 0.13% |
| 9 | Informed Momentum Co LLC | 0.13% |
| 10 | Gabelli | 0.12% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| MADRYN ASSET MANAGEMENT, LP | 31.51% | 13D |
| Chernett Jorey | 16.03% | 13D |
| Parian Ultreia LP | 7.36% | 13G |
| Vanguard Group | 3.50% | 13F |
| Millennium Management | 1.00% | 13F |
| Goldman Sachs | 0.96% | 13F |
| Two Sigma | 0.72% | 13F |
| BlackRock | 0.63% | 13F |
| Geode Capital | 0.49% | 13F |
| State Street | 0.18% | 13F |
Percentages above are of 65,820,344 shares outstanding, as reported by NEURONETICS INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEURONETICS INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
NEURONETICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “NEURONETICS (STIM) 2024-2025 Annual & Special Meetings: Vote Results”, https://proxyvotesnow.com/company/neuronetics-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.